Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oncolys BioPharma, Inc. (JP:4588)
TSE/TYO:4588
Holding JP:4588?
Track your performance easily
4588 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥420.00 - ¥798.00
Previous Close¥774
Volume1.59M
Average Volume (3M)479.34K
Market Cap
¥20.91B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.13
Next Earnings
Feb 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-94.65
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume479,342
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oncolys BioPharma, Inc. News
PremiumCompany Announcements
Oncolys BioPharma Reports Decline in Sales Amidst Uncertainty
PremiumCompany Announcements
Oncolys BioPharma Faces Decreased Sales and Losses4588 FAQ
What was Oncolys BioPharma, Inc.’s price range in the past 12 months?
Oncolys BioPharma, Inc. lowest stock price was ¥420.00 and its highest was ¥798.00 in the past 12 months.
What is Oncolys BioPharma, Inc.’s market cap?
Currently, no data Available
When is Oncolys BioPharma, Inc.’s upcoming earnings report date?
Oncolys BioPharma, Inc.’s upcoming earnings report date is Feb 07, 2025 which is in 86 days.
How were Oncolys BioPharma, Inc.’s earnings last quarter?
Oncolys BioPharma, Inc. released its earnings results on Nov 08, 2024. The company reported -¥22.6 earnings per share for the quarter, missing the consensus estimate of N/A by -¥22.6.
Is Oncolys BioPharma, Inc. overvalued?
According to Wall Street analysts Oncolys BioPharma, Inc.’s price is currently Overvalued.
Does Oncolys BioPharma, Inc. pay dividends?
Oncolys BioPharma, Inc. does not currently pay dividends.
What is Oncolys BioPharma, Inc.’s EPS estimate?
Oncolys BioPharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncolys BioPharma, Inc. have?
Oncolys BioPharma, Inc. has 27,057,600 shares outstanding.
What happened to Oncolys BioPharma, Inc.’s price movement after its last earnings report?
Oncolys BioPharma, Inc. reported an EPS of -¥22.6 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.058%.
Which hedge fund is a major shareholder of Oncolys BioPharma, Inc.?
Currently, no hedge funds are holding shares in JP:4588
---
Technical Analysis
Symbio Pharmaceuticals Limited
―
Chiome Bioscience Inc.
―
Kidswell Bio Corporation
―
Ribomic, Inc.
―
---